Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 83: 503-510, 1997;
8750-7587/97 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fee, L. L.
Right arrow Articles by English, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fee, L. L.
Right arrow Articles by English, M. B.

Journal of Applied Physiology
Vol. 83, No. 2, pp. 503-510, August 1997
CONTROL OF BREATHING, CIRCULATION, AND TEMPERATURE

Enhanced ventilatory and exercise performance in athletes with slight expiratory resistive loading

Lawrence L. Fee, Richard M. Smith, and Michael B. English

Physiology Department, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii 96822

ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
ACKNOWLEDGEMENTS
FOOTNOTES
REFERENCES


ABSTRACT

Fee, Lawrence L., Richard M. Smith, and Michael B. English. Enhanced ventilatory and exercise performance in athletes with slight expiratory resistive loading. J. Appl. Physiol. 83(2): 503-510, 1997.---We determined the cardiorespiratory and performance effects of slight (1.5-3.0 cmH2O) expiratory resistive loading (ERL). Twenty-eight highly fit [peak O2 uptake (VO2 peak) = 63.6 ± 1.3 ml · kg-1 · min-1] athletes (age = 33.5 ± 1.3 yr) performed paired VO2 peak cycle ergometer tests (control vs. ERL). End-expiratory lung volume was separately determined in a subset of subjects (n = 12) at steady-state 75% maximum power output (POmax) and was found to increase (0.67 ± 0.29 liter) with ERL. In the VO2 peak tests, peak expiratory pressure at the mouth, mean inspiratory flow, minute ventilation, and O2 pulse were greater with ERL at every intensity level (i.e., 75, 80, 85, and 90% POmax). Increased minute ventilation was largely due to a trend toward increased tidal volume (P < 0.05 at 80% POmax). O2 uptake was greater at 90% POmax with ERL. Increased O2 pulse with ERL at comparative workloads suggests that stroke volume was augmented with ERL. Also, with ERL, athletes attained higher VO2 peak (63.0 ± 1.4 vs. 60.1 ± 1.3 ml · kg-1 · min-1) and greater POmax (352.0 ± 9.9 vs. 345.7 ± 9.5 W). We conclude that elevated end-expiratory lung volume in response to slight ERL during strenuous exercise served to attenuate both airflow and blood flow limitations, which enhanced exercise capacity.

expiratory resistance; exercise capacity; airflow limitation; end-expiratory lung volume


INTRODUCTION

AIRFLOW LIMITATION (FL) during exercise hyperpnea is the consequence of portions of the expiratory flow-volume envelope becoming tangent to the flow-limiting (effort-independent) slope of the maximal expiratory flow-volume (MEFV) curve (18). FL over a significant portion of the expiratory tidal volume (VT) has been demonstrated over the range of intense to maximal exercise, developing at >= 83% of maximal aerobic capacity (VO2 max) in young (mean 25 ± 1 yr) competitive endurance athletes (19). In exceptionally fit older athletes, FL begins to occur at 50-75% VO2 max (18). FL at lower intensities in fit, older athletes is due to loss of elastic recoil of the lung (6). FL can compromise minute ventilation (VE) (16), and it has been speculated that the positive expiratory pleural pressures (Ppl) attendant to FL may impede venous return (25). One circumstance that contributes to the development of FL is decrease in functional residual capacity (FRC) or end-expiratory lung volume (EELV) with exercise (13). When EELV is lowered, exercise expiratory tidal flow shifts closer to the MEFV envelope (3), increasing the potential for FL and reducing the maximal predicted VE (16). Furthermore, at lung volumes below resting FRC, airway closure in dependent lung regions adds to maldistribution of inspiratory gas flow (13).

In healthy subjects, EELV has been observed to progressively decrease by ~0.7 liter during heavy exercise. EELV remains depressed until exercise becomes intense and then gradually returns to near-resting FRC at VO2 max (17, 18). Despite this tendency of EELV to recover to its near-resting FRC position, a progressively greater portion of the VT becomes flow limited as exercise becomes more intense (18, 19).

In principle, expiratory resistive loading (ERL) might experimentally elevate EELV to a volume at which expiratory flow remains entirely within the MEFV curve (1) and away from the FL experienced at lower lung volumes (19). One frequently observed consequence of ERL (7, 10, 11, 22) has been increased EELV. Other favorable responses to ERL have been increased VT and mean inspiratory flow (VT/TI) (11, 14, 24). However, concomitant with the increases in EELV associated with ERL, typically there have been adverse alterations, such as compromised VE (11, 24) and mean expiratory flow (VT/TE) (22, 24) and decreased cardiac output (perhaps secondary to reduced venous return in patients with chronic obstructive pulmonary disease due to elevated intrathoracic pressures) (23). However, our preliminary work (5) suggested that the degree of ERL employed in previous studies may have been too great (5.0-40.0 cmH2O) (7, 10, 11, 14, 22, 24) to elicit cardiorespiratory benefit. In a prior study, with only slight reductions in the internal diameter of the expiratory port of the Hans Rudolph low-resistance three-way valve, we observed mitigated exercise-induced hypoxemia (EIH) in highly fit, endurance-trained athletes at mild altitude (5). Because our former EIH-ERL study suggested that one of our experimental resistors offered beneficial resistance to expiration during strenuous exercise, we chose to conduct a sea-level study utilizing the same expiratory flow resistor used at altitude (5). In the present graded peak aerobic capacity (VO2 peak) study, we measured peak expiratory pressure at the mouth (PEpeak) and changes in cardiorespiratory variables in highly fit endurance athletes. In a companion study, we determined exercise EELV in a representative subset of athletes (n = 12) with and without the experimental expiratory orifice during heavy, steady-state exercise at 75% of maximum power output (POmax).


METHODS

Subjects. All subjects (n = 28) were actively competitive male (n = 23) and female (n = 5) cyclists and/or triathletes (age = 33.5 ± 1.3 yr, VO2 peak = 63.6 ± 1.3 ml · kg-1 · min-1). They were studied with their informed consent, and all procedures were approved by the Human Experimentation Committee of the University of Hawaii at Manoa. Selected physical characteristics and lung volumes of the subjects are given in Table 1. All paired testing with a given subject was completed within 7 days. Subjects were asked to refrain from strenuous activity on the day before testing. All 28 subjects performed paired VO2 peak tests. Subsequently, EELV at steady-state 75% POmax was determined in a random subset of the VO2 peak-tested subjects (n = 12): 11 men and 1 woman. Their mean age (34.3 ± 2.3 yr), VO2 peak (68.7 ± 1.5 ml · kg-1 · min-1), residual volume (1.52 ± 0.11 liters), vital capacity (5.31 ± 0.39 liters), and total lung capacity (7.17 ± 0.26 liters) differed only slightly from the VO2 peak-tested group.

Table  1.   Subject characteristics
Mean ± SE Range

Age, yr 33.5 ± 1.3  21-51
Height, cm 172.0 ± 1.4  165-192
Weight, kg 70.1 ± 1.5  51.8-80.0
 VO2peak, ml · kg-1 · min-1 63.6 ± 1.3  53.6-78.2
RV, liters 1.45 ± 0.07  1.02-2.47
VC, liters 5.73 ± 0.17  4.78-8.03
TLC, liters 7.21 ± 0.21  5.66-10.35
FVC,* 111.30 ± 2.42  91-137
FEV1.0,* 112.10 ± 2.72  89-133

Values are representative of 28 subjects (23 men and 5 women). VO2 peak, peak aerobic capacity; RV, residual volume; VC, vital capacity; TLC, total lung capacity; FVC, forced vital capacity; FEV1.0, forced expiratory volume in 1 s. * Percentage of normal predicted values from Schiller (Schiller derivations based on Knudson, Crapo, and Morris).

Cycle ergometry. All tests were performed on an electrically braked cycle ergometer (model 800, Ergometrics) that was integrated with a Schiller AT-6 (CH 6340), a multiplex system capable of monitoring electrocardiogram (ECG), testing pulmonary function, and controlling the exercise protocol. During an initial familiarization session, subjects were asked to choose a power output (PO, in W) that was comfortable, yet somewhat demanding, and to indicate at what pedal cadence they normally cycled. These became the starting PO and the fixed cadence for all testing. Before every test, subjects were given the same warm-up, which began at 135 W on the cycle ergometer and was increased 10 W/min for a total of 8 min. A 1-min interval/transition, during which the subjects maintained their fixed cadence at zero pedal resistance, followed the 8-min warm-up. Every test (i.e., those in the VO2 peak series or the steady-state at 75% POmax series) began immediately after the transition interval and commenced with the initial minute at the subject's predetermined, fixed cadence and chosen PO. Group mean heart rate (HR) at starting PO was 131.0 ± 2.9 (SE) beats/min. Workload was increased by 10 W/min thereafter. Subjects were asked to keep their cadence within 1-2 revolutions/min (rpm) of the digital, instantaneous rpm readout at all times, which we strictly monitored along with current wattage.

ERL. During the control tests, subjects breathed through a three-way low-resistance valve (model 2700, Hans Rudolph). The three-way valve was mounted in such a way as to ensure a relatively consistent body position during the tests. ERL was effected by reducing the internal diameter of the expiratory port of the three-way valve from 28.6 to 22.2 mm at its juncture with the gas-conducting tubing. Figure 1 regressions are derived from the pooled data of all subjects during VO2 peak testing and present the profiles of PEpeak vs. VE in without (control) and with ERL. The control data were best described by a first-order polynomial, whereas the ERL data were best described by a second-order polynomial. In all comparisons within this study the order of presentation of expiratory orifices was alternated, such that ERL was presented first in one-half of the subjects, and the subjects were naive to the intervention. PEpeak was sampled from a sampling port hose barb in the housing of the three-way valve. A 0.5-m section of rigid plastic tubing (2 mm ID) connected the barb to a volumetric pressure transducer (model PT-5A, Grass), which was linear over 0.0-12.0 cmH2O. Before each test the transducer was calibrated with a water manometer. The Grass transducer was interfaced with a strain-gauge coupler (model 2193, Harvard Apparatus). During all tests, PEpeak traces were recorded on a 12-speed chart mover (model 486, Harvard Apparatus). The chart speed was maintained at 0.025 cm/s, except for single-breath traces (PE), which were recorded at 5.0 cm/s.
Fig. 1. Relationship of peak expiratory pressure at mouth (PEpeak) to minute ventilation (VE) in control condition (Hans Rudolph valve 2700) and with expiratory resistive loading (ERL). Data are pooled for all subjects (n = 28). Confidence level: P <=  0.05. Best-fit lines: control, 1st-order polynomial; ERL, 2nd-order polynomial.
[View Larger Version of this Image (16K GIF file)]

VO2 peak testing. Each subject performed two graded VO2 peak cycle ergometer tests to exhaustion: one with ERL and one without (control). In each test, VO2 peak was considered the highest O2 consumption (VO2) maintained for a full minute. The higher of the two VO2 peak values was used to determine group mean VO2 peak (Table 1). POmax (in W) was considered to be the higher last full-minute wattage attained in either of the two VO2 peak tests. We did not validate the reproducibility in the POmax tests. We did, however, randomize the presentation of the orifices (control vs. ERL).

Steady-state testing. Subjects performed two graded cycle ergometer tests (with and without ERL) up to a steady state of 75% POmax, at which point EELV was determined. The EELV test protocol began just as in the VO2 peak tests, except at 75% POmax the wattage was manually fixed and maintained for 4 min. With the assumption of steady state (28), metabolic data associated with EELV were collected and averaged in the 3rd min. At the beginning of the next (4th) minute, we switched the subject to the closed-circuit He-rebreathing system for 30 s.

EELV determination: He dilution. EELV was determined by He dilution. Two manual, directional control, three-way Y-shaped valves (model 2100 C, Collins) were used to switch from the open-circuit gas-evaluating system to the closed-circuit He residual volume apparatus (model P-1300, Collins) rebreathing system with a 13.5-liter spirometer. Before each test the system was purged, and the He analyzer was calibrated with a known concentration of He-containing gas (5.0%), purged again, and loaded with 4 liters of O2 and 0.6 liter of He. During the rebreathing (30 s), 100% O2 was infused at a rate that maintained the system volume relatively constant. The system was scrubbed of CO2 by barium hydroxide lime, US Pharmacopoeia (Collins absorbent granules). Final He concentrations were recorded when further gas mixing elicited no further changes in He concentration. All volumes were converted to BTPS.

Measurements. All tests were conducted under relatively stable environmental conditions: 20-21°C, 758-765 Torr, and 50-65% relative humidity. Barometric pressure was ascertained from the National Weather Service telephone recording, which was updated hourly. Laboratory temperature and relative humidity were determined from a thermometer/hygrometer (model 63-844, Micronta). Arterial O2 saturation (SaO2) was determined with an ear oximeter (model OPS-200, Satlite), which was internally self-calibrated before each exercise test. SaO2 was measured only in the VO2 peak tests. Each subject's ECG and HR were continuously monitored during exercise testing with the Schiller AT-6 ECG system. Instantaneous reports of ECG and HR were given on the screen of a monitor (model 710 A, Mitsuba) interfaced with the AT-6 system. Before every exercise test the ECG monitor was calibrated with the Physio-dyne HR calibrator (ECG-Cal).

Ventilatory variables were monitored via standard open-circuit spirometry. Fractional concentrations of expired O2 (FEO2) and CO2 (FECO2) were determined by Ametek analyzers (models S-3A/I and CD-3A, respectively). Before every test, these analyzers were calibrated with two reference gases of the following concentrations: 21.03% O2 and 5.02% CO2 or 15.00% O2 and 0.03% CO2. Inspired ventilation volume (VI) was determined with a flow transducer (model K520, K. L. Engineering). These measurements of FEO2, FECO2, and VI and those of SaO2 and HR (via Physio-dyne HR computer/ECG-HR3) were integrated with a CompuAdd 433 (model A000) computer and monitor (model 51109) that ran the Ametek O2 uptake system OCM-2 program. The OCM-2 recorded SaO2, HR, the respiratory exchange ratio (R), VE, breathing frequency (f ), VT, duration of expiration, inspiration, and breathing cycle (TE, TI, and TT, respectively), TI/TT, VT/TE, VT/TI, FEO2, FECO2, VO2, CO2 production (VCO2), and O2 pulse (VO2/HR). VE was determined from VI and R, with differences in VO2 and VCO2 accounted for and corrected by the OCM-2 program. All dynamic ventilatory volumes were converted to BTPS and, along with SaO2 and HR, were averaged to minute intervals by the OCM-2.

EELV and resting residual volume measurements were determined by standard He dilution and reflect allowances for O2 consumed or added to the system. CO2 was presumed to be entirely removed from the system. Vital capacity (VC), forced VC, and forced expiratory volume in 1 s were determined with the Schiller AT-6 pulmonary function testing equipment. Predicted values were based on a composite derived by Schiller (manual issue 07.1991) from the work of Knudson, Crapo, and Morris.

Data analysis. Because the majority of subjects attained different levels of PO in each of their VO2 peak tests, POmax was defined to be the higher full-minute PO of the two VO2 peak tests. The virtue of this method is that it ensured that every intrasubject comparison was made at identical PO or wattage levels. It also provided a criterion for normalizing the data into percentages of POmax.

Inherent in the fact that if a given subject accomplished two different POmax levels is that he/she would have only one set of data at 100% POmax and that there was no reference for comparison at that level. Also, in many cases there is no reference for comparison at 95% POmax. Therefore, the data were normalized with reference to POmax at 75 (heavy exercise), 80, 85, and 90% POmax (intense exercise) by interpolation.

Statistics. All data were analyzed using the SigmaStat program. Repeated measures analyses of variance were performed on the VO2 peak data, and where significant differences (P <=  0.05) between control and treatment (ERL) were indicated, the Student-Newman-Keuls post hoc test was performed to determine at what level(s) of POmax there was a significant (P <=  0.05) difference. Steady-state data were analyzed using Bonferroni's pairwise multiple comparisons to determine whether there were significant (P <=  0.05) differences between control and treatment (ERL).


RESULTS

Graded VO2 peak test series comparisons. Mean test duration was 13.1 ± 0.73 min. There was slight but statistically significant EIH in control and ERL tests at 75, 80, 85, and 90% POmax (Fig. 2) compared with resting sea-level SaO2; although SaO2 with ERL tended to be greater, there was no significant difference in SaO2 between control and ERL at rest or at any level of intensity. PEpeak was greater (P <=  0.05) with ERL at every workload (Table 2). VE with ERL was greater (P <=  0.05) at 80, 85, and 90% POmax (Table 2, Fig. 3). VT was consistently greater with ERL over the comparison range but significantly greater (P <=  0.05) only at 80% POmax, where it was greater by 200 ml (Fig. 4). The increase in VT with ERL averaged 144 ml from 75 to 90% POmax. This trend toward increased VT at 80, 85, and 90% POmax in concert with relatively high f accounted for the increase in VE. The increase of VT in response to ERL in our study is consistent with the observations of previous studies (13, 24). From 75 to 90% POmax, f was unchanged. This varies from the results of previous investigators who observed decrements in f with ERL during exercise (11, 14). VT/TI was greater (P <=  0.05) with ERL at every workload (Fig. 5). VT/TE tended to be greater with ERL and significantly (P <=  0.05) greater at 75% POmax. HR was consistently lower (>= 2.0 beats/min) throughout with ERL (Fig. 6) but statistically lower only at 75% POmax. Relative VO2 was nonsignificantly higher (<= 3.2 ml · kg-1 · min-1) from 75 to 85% POmax with ERL and significantly greater (P <= 0.05) with ERL at 90% POmax. The clear tendencies for elevated VO2 and lowered HR produced an O2 pulse that was significantly greater with ERL at every workload (Fig. 7).
Fig. 2. Arterial O2 saturation (SaO2) at rest and as a percentage of maximum power output (%POmax) during graded maximal exercise with (black-square) and without ERL (bullet ). Values are means ± SE. * Significantly (P <=  0.05) different from resting values (with and without ERL).
[View Larger Version of this Image (15K GIF file)]

Table  2.   PEpeak vs. VE at progressive levels of exercise intensity
%POmax PEpeak,* cmH2O
 VE,dagger l/min
Control ERL  Delta Control ERL  Delta

75 1.1 1.3 0.2Dagger 82.6 85.9 3.3
80 1.2 1.6 0.4Dagger 93.1 97.2 4.1Dagger
85 1.5 1.9 0.4Dagger 104.6 109.5 4.9Dagger
90 1.8 2.3 0.5Dagger 119.9 124.4 4.5Dagger

Values are representative of 28 subjects. PEpeak, peak expiratory pressure; VE, minute ventilation; POmax, maximum power output; ERL, expiratory resistive loading. * SE ± 0.113; dagger SE ± 3.42.  Dagger Significant (P <=  0.05) difference.


Fig. 3. VE vs. %POmax with (black-square) and without ERL (control, bullet ). Values are means ± SE; n = 28. * Significantly (P <=  0.05) different from control.
[View Larger Version of this Image (14K GIF file)]


Fig. 4. Tidal volume (VT) vs. %POmax with (black-square) and without ERL (bullet ). Values are means ± SE; n = 28. * Significantly (P <=  0.05) different from control.
[View Larger Version of this Image (13K GIF file)]


Fig. 5. Mean inspiratory flow (VT/TI) vs. %POmax with (black-square) and without ERL (bullet ). Values are means ± SE; n = 28. * Significantly (P <= 0.05) different from control.
[View Larger Version of this Image (12K GIF file)]


Fig. 6. Heart rate (HR) vs. %POmax with (black-square) and without ERL (bullet ). Values are means ± SE; n = 28. * Significantly (P <=  0.05) different from control.
[View Larger Version of this Image (11K GIF file)]


Fig. 7. O2 pulse (VO2/HR, where VO2 is O2 consumption) vs. %POmax with (black-square) and without ERL (bullet ). Values are means ± SE; n = 28. * Significantly (P <=  0.05) different from control.
[View Larger Version of this Image (14K GIF file)]

Subjects attained 1.8% greater POmax (352.0 ± 9.9 vs. 345.7 ± 9.5 W; Fig. 8) and 4.8% higher VO2 peak (63.0 ± 1.4 vs. 60.1 ± 1.3 ml · kg-1 · min-1, both P <=  0.05) with ERL (Fig. 9).
Fig. 8. POmax with and without ERL. Values are means ± SE; n = 28. * Significantly (P <=  0.05) different from control.
[View Larger Version of this Image (11K GIF file)]


Fig. 9. Peak O2 consumption (VO2 peak) with and without ERL. Values are means ± SE; n = 28. * Significantly (P <=  0.05) different from control.
[View Larger Version of this Image (10K GIF file)]

Steady state at 75% POmax comparisons. Mean test duration was 17.0 ± 0.1 min. Table 3 presents the essential cardiorespiratory data, comparing control with ERL during steady-state exercise at 75% POmax. VE is somewhat higher than that observed at 75% POmax in the VO2 peak studies. This disparity can be explained in part by a ventilatory drift (4.96 ± 1.35 and 4.12 ± 1.19 l/min in control and ERL, respectively) that we observed during the 4 min of cycling leading to steady state.

Table  3.   Respiratory variables during steady state at 75% POmax
Control ERL  Delta

PEpeak, cmH2O 1.1 ± 0.13  1.5 ± 0.17  0.4 ± 0.01 
EELV, liters 2.45 ± 0.16  3.11 ± 0.24  0.67 ± 0.29*
EILV, liters 5.22 ± 0.22  5.92 ± 0.28  0.70 ± 0.28*
IRV, liters 1.95 ± 0.27  1.25 ± 0.17   -0.70 ± 0.28*
 VE, l/min 98.7 ± 2.9  105.9 ± 4.4  7.2 ± 2.9 
VT/TE, l/s 4.42 ± 0.23  4.98 ± 0.36  0.56 ± 0.25 
VT/TI 2.64 ± 0.06  2.76 ± 0.09  0.12 ± 0.06 
VT, ml 2778 ± 110.5  2808 ± 127.8  30.3 ± 61.1 
f, breaths/min 36.01 ± 1.62  38.24 ± 1.86  2.22 ± 10 
HR, beats/min 154.8 ± 3.7  156.0 ± 4.7  1.2 ± 1.6 
 VO2, ml · kg-1 · min-1 52.0 ± 1.1  52.8 ± 1.4  0.8 ± 0.7 
TE, s 0.65 ± 0.04  0.59 ± 0.04   -0.06 ± 0.04 
TI, s 1.11 1.01  -0.10
TI/TT 0.66 0.64  -0.02

Values are means ± SE; n = 12. EELV, end-expiratory lung volume; EILV, end-inspiratory lung volume; IRV, inspiratory reserve volume; VT/TE, mean expiratory flow; VT/TI, mean inspiratory flow; f, breathing frequency; VT, tidal volume; HR, heart rate; VO2, relative O2 consumption; TE, time of expiration; TI, time of inspiration; TI/TT, duty cycle. * Significantly different (P <=  0.05, Bonferroni's pairwise multiple comparisons).

Breathing patterns. In the steady state and in graded maximal exercise testing, PE traces suggest that there were frequently three noticeable differences in breathing patterns between control and ERL. Several examples of these differences in pressure profile are shown in Fig. 10. With ERL there was 1) a sharper initial rise in PE, 2) a prolonged plateau of PE, and 3) a more abrupt decline in PE at end expiration than in control.
Fig. 10. Single-breath expiratory pressure at mouth (PE) vs. time without (A) and with ERL (B). Values >= 0.0 cmH2O are expiratory pressure tracings; values <= 0.0 cmH2O are incomplete inspiratory pressure tracings. Max, maximum.
[View Larger Version of this Image (56K GIF file)]


DISCUSSION

In the range of exercise intensity of this study, it is probable that the athletes experienced various degrees of expiratory FL (19). FL over a significant portion of expiratory VT has been demonstrated over the range of intense to maximal exercise (the range of our study) and, specifically, developed at ~83% of VO2 max in young (25 ± 1 yr) competitive elite athletes (19). In exceptionally fit older (69 ± 1 yr) athletes, this occurred at 50-75% VO2 max (18). FL at lower intensities in fit, older athletes is due to loss of elastic recoil of the lung (6). With losses in elastic recoil, the static lung recoil pressure at any given lung volume is lower, so greater effort (Ppl) is required during expiration (18). In our graded VO2 peak study, we suspect that slight ERL may have somewhat attenuated the effects of FL during heavy exercise and effected measurable increases in exercise performance and in several cardiorespiratory variables; in particular, we observed increased POmax, VE, and O2 pulse, which are reported here for the first time. Also, the increase in VE is contrary to the findings of all other loaded expiration studies (10, 11, 14, 24) of which we are aware.

Prior ERL studies. In previous ERL studies in which there were no cardiorespiratory benefits, there were three potentially limiting factors: 1) the degree of ERL employed, 2) the aerobic capacity of the subjects, and 3) the relative physical demand of the protocol, since in healthy subjects FL can occur only during strenuous exercise (3, 18, 19). One or several of these factors in previous studies may have been inappropriate to elicit cardiorespiratory benefit.

First, the ERL employed in previous studies appears to have been overbearing, having ranged from 5.0 to 40.0 cmH2O (8, 11, 22, 24). Second, to our knowledge, there has not been a study employing ERL in which the subjects have had superior aerobic capacity. Typically, the subjects' mean VO2 max values have been <40 ml · kg-1 · min-1 (8, 22). Healthy subjects in these ranges of aerobic capacity would not place the ventilatory demand on the pulmonary system, which would precipitate FL (19). The third factor precluding cardiorespiratory benefit in response to ERL is that tests have been resting tests or low-intensity submaximal exercise tests. Such protocols would not precipitate FL, even in highly fit subjects (19).

Respiratory responses to ERL. Neither TI nor TE changed in response to ERL. Previous investigators have observed an increase in TI and TE (24) or no change in TI or TE with ERL (7). A prolongation of TE observed by Goldstein and co-workers (8) was proportional to the amount of ERL, which ranged from 5.0 to 30.0 cmH2O, far more than the ERL employed in the present study.

EELV typically increases in response to expiratory loading (7, 8, 11, 22), increasing up to 1.71 ± 0.67 liters in response to extreme ERL (7). Not unexpectedly, in the steady-state (75% POmax) comparisons, EELV was increased with ERL. However, what was surprising, in view of previous studies employing ERL, was the magnitude of increase in EELV (0.67 ± 0.29 liter) in response to so little increase in PEpeak (0.4 ± 0.1 cmH2O) with ERL vs. control. Johnson and colleagues (20) observed a consistently slightly higher EELV (120 ± 10 ml, P < 0.01) with the two-tracer-gas method than with the He-dilution method employed in this study. This disparity was greatest during heavy exercise: 158 ± 40 and 209 ± 24 ml with equilibration times of 7 ± 1 and 20 s, respectively. Because this consistently slight and directional error would have been common to control and ERL trials in our study, we surmise that the observed differences in EELV with ERL were not significantly affected by the He method.

PEpeak may have been a bit lower in steady state than in the graded exercise tests (which increased 10 W/min), because by the 4th min at 75% POmax a more comfortable breathing pattern had been established, with a little less emphasis on the initial expiratory effort.

The cumulative total resistance of the respiratory system is ~3 cmH2O · l-1 · s, with resistance being somewhat greater during expiration than inspiration (4). The majority of this resistance is offered by the upper airways and, in particular, by the glottis (8). Normally, a great deal of expiratory glottal resistance is progressively lost during graded exercise in response to increased airflow rates (26). This phenomenon has been observed during hyperventilation (15) and exercise hyperpnea (4). In our study the aperture chosen for ERL created increasingly higher PEpeak (Fig. 1), inasmuch as glottal braking presumably diminished with increasing VE (15).

The ERL presented during the steady-state exercise at 75% POmax apparently offered sufficient stimulus to shift EELV upward and away from the FL, which occurs during heavy to maximal exercise. VT/TE was unchanged with ERL, in contrast to previous studies in which reductions in VT/TE were observed with ERL (22, 24). Although these larger ERL values (5 and 8 cmH2O, respectively) did increase EELV, their thwarting effects on expiratory flow probably contributed to a reduced VE. The ERL employed here at steady state (1.5 ± 0.2 cmH2O) represents quite modest ERL compared with that utilized in prior studies (7, 10, 11, 14, 22, 24) and did not affect VE adversely. In two of these studies, ERL and VE were inversely related (10, 24).

Johnson and colleagues (19) suggested that exerting greater effort earlier in the expiratory phase (when airflow is still effort dependent) would be one strategy by which to mitigate FL. With ERL, this strategy appears to be at work, as observed in the sharp rise in expiratory pressure at the commencement of the expiratory phase in the single expiratory breath tracings (Fig. 10). Also, there was a pattern of prolonged elevation (plateau) of PE with ERL (Fig. 10). This may have served to distend the airways and may have effectively prolonged the effort-dependent stage of expiration as well.

VO2 peak test series. In addition to the normal expansion of VT to a plateau of 50-60% of VC (30) with graded exercise, there is a further increase in VT with ERL (14, 24). Throughout our comparison VO2 peak tests, VT was greater and significantly greater (P <=  0.05) at 80% POmax with ERL vs. control (Fig. 4), with little or no change in f with ERL. Further expansion in VT, after it has reached a plateau, is limited by FL, as described by the descending profile/envelope of the MEFV curve (3), and is relatively fixed for a given EELV (12). Because we did observe increases in VT in response to ERL, we infer that FL was ameliorated.

Because in these graded VO2 peak tests we employed the same resistor used in the EELV series, we presumed that there had been an increase in EELV in response to ERL in the graded VO2 peak series and that the increased VT (Table 3) was correspondingly shifted to higher lung volumes. We believe that this evident increase in VT due to the probable increase in EELV explains the significantly increased VE at 80, 85, and 90% POmax (Fig. 3). In the steady-state comparisons, VT was not significantly greater with ERL. We suspect that at this level of intensity, i.e., 75% POmax, FL had not yet become a problem. As mentioned above, in the VO2 peak tests, VT was significantly greater.

ERL provokes greater inspiratory effort (10, 11). The increased end-inspiratory lung volume (Table 3) offers circumstantial evidence of increased inspiratory effort with ERL. However, opting to do more inspiratory work appears to be a beneficial trade-off for our athletes. Although breathing at hyperinflated lung volumes may predispose the inspiratory muscles to fatigue (3), in our study, it does not appear that ERL presented any such liability. Fatigability of respiratory muscles has been shown to be a function of the percentage of respiratory effort expended vs. the maximal capacity for muscular effort (29). Our highly trained endurance athletes very likely had developed superior respiratory muscle strength, so that absolute increases in respiratory muscle effort would represent smaller percentages of maximum capacity for muscular effort, making them less susceptible to respiratory muscle fatigue than less fit subjects (9).

The increase in end-inspiratory lung volume with ERL to 77.9 ± 2.9% VC vs. 66.3 ± 4.2% VC (control) would not appear to have required a great increase in inspiratory effort, since 77.9% VC is still within the range of optimum compliance (i.e., 20-80% VC), i.e., within the range in which the elastic work of breathing is at a minimum (30). With ERL there still remained 1.25 ± 0.17 liters of inspiratory reserve volume (Table 3). We surmise that the observed increases in VE associated with ERL were not at the expense of extraordinary inspiratory effort but rather more probably due to a moderate and manageable increase in inspiratory effort. Our subjects did not complain of increased work of breathing with ERL. In fact, anecdotally, many of the athletes in our study, without solicitation, commented that "it felt easier" or "I felt stronger this time (or last time)," unknowingly referring to the ERL test. It is also likely that the increase in EELV with ERL reduced the energy requirement for expiration. With ERL, EELV was elevated from 16.7 ± 2.9 to 28.0 ± 3.4% VC and to a more favorable position on the compliance curve.

There was a nonsignificant increase in VO2 with ERL from 75 to 85% POmax, which became significant (P <=  0.05) at 90% POmax. A partial explanation for this elevated VO2 during ERL would be the increased energy requirement to perform increased inspiratory work. However, the athletes' performances were not compromised by this increased energy demand, and it would appear that some fraction of the increased VO2 peak observed with ERL was delivered to the working skeletal muscle, which produced (P <=  0.05) greater POmax (Fig. 9).

Effective Ppl. When exercising athletes reach FL, Ppl has met or exceeded effective Ppl (Peff), which is the minimal pressure to drive maximal expiratory flow, as described by isovolume pressure-volume curves (1). Exceeding Peff represents a waste of energy and can lead to a decrease in expiratory flow from dynamic compression of airways (21). However, during breathing at elevated lung volumes, as the athletes in our study did with ERL, the Peff is raised (2), and this can move the entire VT away from the flow-limiting pressures reached at lower lung volumes (3), thereby enabling the athlete to exert more effective expiratory pressure. Ordinarily, only a small fraction of maximum expiratory effort is required to generate maximum expiratory flow (29). In fact, it is estimated that at >40% of maximal expiratory effort, there is no further effect on expiratory ventilation (29). At heavy workloads (VE >=  120 l/min) the cost of breathing increases markedly because of the expiratory work done against FL (17). In our study the strategy/response to ERL may have been to effectively divert effort from "wasted" expiratory work, where expiratory Ppl > Peff, to greater inspiratory activity. With this strategy, FL may have been prevented and, consequently, VE increased.

Breathing at elevated EELV, in response to ERL, had significant cardiovascular implications as well. In the graded VO2 peak comparisons, O2 pulse was greater (P <=  0.05) from 75 to 90% POmax (Fig. 7), yet SaO2 was only ~1% greater with ERL (Fig. 1). Because there is little reason to suspect that ERL caused decreased mixed venous O2 content and because these comparisons with and without ERL were made at identical workloads, increased O2 pulse suggests increased stroke volume, probably secondary to augmented venous return with ERL. Besides the deleterious ventilatory effects of having Ppl exceed Peff, excessive Ppl, which is likely to occur in very strenuous exercise (3, 18, 19), can impede venous return (25). Furthermore, elevated EELV, as was observed in our study in response to ERL, is associated with decreased pulmonary vascular resistance (27). We suggest that increased stroke volume, in concert with increased VE, very likely contributed to the increases in VO2 peak and POmax.

In conclusion, we infer from our findings that increased EELV in response to slight ERL during strenuous exercise served to attenuate airflow and blood flow limitations, which otherwise may have been the product of excessive Ppl developed during active expiration at lower lung volumes. We further conclude that appropriate ERL during strenuous exercise can enhance ventilatory and exercise capacity.


ACKNOWLEDGEMENTS

We gratefully acknowledge the technical assistance of Chuck Daniels, Robert and Peggy Dinman, Ron E. Dunn, Jeff Hall, J. M. Hanna, David L. Lally, Charles K. Matsuda, Hurley McBrierty, Ken Mito, and Stephen Wehrman.


FOOTNOTES

Address for reprint requests: L. Fee, 1222 Manu Mele St., Kailua, HI 96734.

Received 16 April 1996; accepted in final form 4 April 1997.


REFERENCES

1. Beck, K., T. Babb, B. Staats, and R. Hyatt. Dynamics of breathing during exercise. In: Exercise, edited by B. Whipp, and K. Wasserman. New York: Dekker, 1991, vol. 52, p. 78-79. (Lung Biol. Health Dis. Ser.)
2. Bouhuys, A., and B. Jonson. Alveolar pressure, airflow rate, and lung inflation in man. J. Appl. Physiol. 22: 1086-1100, 1967[Free Full Text].
3. Bye, P., G. Farkas, and C. Roussos. Respiratory factors limiting exercise. Annu. Rev. Physiol. 45: 439-451, 1983[Medline].
4. England, S., J. Bartlett, and A. Daubenspeck. Influence of human vocal cord movements on airflow and resistance during eupnea. J. Appl. Physiol. 52: 773-779, 1982[Abstract/Free Full Text].
5. Fee, L., L. Cordain, A. Tucker, D. Lally, R. Smith, J. Cebrick, and G. Holst. Cardiorespiratory responses to increased expiratory resistance during exercise (Abstract). FASEB J. 6: 5032, 1992.
6. Frank, N., J. Mead, and B. Ferris, Jr. The mechanical behavior of the lungs in healthy elderly people. J. Clin. Invest. 36: 1680-1687, 1957.
7. Garrard, C., and D. Lane. The pattern of stimulated breathing in man during non-elastic expiratory loading. J. Appl. Physiol. 279: 17-29, 1978.
8. Gautier, R., J. Remmers, and D. Bartlett. Control of the duration of expiration. Respir. Physiol. 18: 205-221, 1978.
9. Gimenez, M., V. Cereceda, D. Teculescu, F. Aug, and M. Laxenaire. Square-wave exercise test (SWEET) for training and assessment in trained and untrained subjects. Eur. J. Appl. Physiol. 49: 379-387, 1982.
10. Goldstein, I., S. Goldstein, J. Urbanetti, and N. Anthonisen. Effects of expiratory loading during steady-state exercise. J. Appl. Physiol. 39: 697-701, 1975[Abstract/Free Full Text].
11. Gothe, B., and N. Cherniack. Effects of respiratory loading on respiration in humans. J. Appl. Physiol. 49: 601-608, 1980[Abstract/Free Full Text].
12. Hanson, P., A. Claremont, J. Dempsey, and W. Reddan. Determinants and consequences of ventilatory responses to competitive endurance running. J. Appl. Physiol. 52: 615-623, 1982[Abstract/Free Full Text].
13. Henke, K., M. Sharratt, D. Pegelow, and J. Dempsey. Regulation of end-expiratory volume during exercise. J. Appl. Physiol. 64: 135-146, 1988[Abstract/Free Full Text].
14. Hill, A., D. Kaiser, J. Lu, and D. Rochester. Steady-state response of conscious man to small expiratory resistive loads. Respir. Physiol. 61: 369-381, 1985[Medline].
15. Hyatt, R., and R. Wilcox. Extrathoracic airway resistance in man. J. Appl. Physiol. 16: 326-330, 1961[Abstract/Free Full Text].
16. Jensen, J., S. Lyager, and O. Pedersen. The relationship between maximal ventilation, breathing pattern and mechanical limitation of ventilation. J. Physiol. (Lond.) 309: 521-532, 1980[Abstract/Free Full Text].
17. Johnson, B., M. Babcock, O. Suman, and J. Dempsey. Exercise-induced diaphragmatic fatigue in healthy humans. J. Physiol. (Lond.) 460: 385-405, 1993[Abstract/Free Full Text].
18. Johnson, B., W. Reddan, D. Pegelow, K. Seow, and J. Dempsey. Flow limitation and regulation of residual capacity during exercise in a physically active aging population. Am. Rev. Respir. Dis. 143: 960-967, 1991[Medline].
19. Johnson, B., K. Saupe, and J. Dempsey. Mechanical constraints on exercise hyperpnea in endurance athletes. J. Appl. Physiol. 73: 874-886, 1992[Abstract/Free Full Text].
20. Johnson, B., K. Seow, D. Pegelow, and J. Dempsey. Adaptation of the inert gas FRC technique for use in heavy exercise. J. Appl. Physiol. 68: 802-809, 1990[Abstract/Free Full Text].
21. Mead, J., J. Turner, P. Macklem, and J. Little. Significance of the relationship between lung recoil and maximum expiratory flow. J. Appl. Physiol. 22: 96-108, 1967.
22. Pellegrino, R., V. Brusasco, J. Rodarte, and T. Babb. Expiratory flow limitation and regulation of end-expiratory lung volume during exercise. J. Appl. Physiol. 74: 2552-2558, 1993[Abstract/Free Full Text].
23. Pick, R., J. Handler, and A. Friedman. The cardiovascular effects of positive end-expiratory pressure. Chest 82: 345-350, 1982[Free Full Text].
24. Poon, C., M. Younes, and C. Gallagher. Effects of expiratory resistive load on respiratory motor output in conscious humans. J. Appl. Physiol. 63: 1837-1845, 1987[Abstract/Free Full Text].
25. Potter, W., S. Olafsson, and R. Hyatt. Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J. Clin. Invest. 50: 910-919, 1971.
26. Stanescu, D., J. Pattijn, J. Clement, and K. van de Woestijn. Glottis opening and airway resistance. J. Appl. Physiol. 32: 460-466, 1972[Free Full Text].
27. Wagner, P., and G. Gale. Ventilation-perfusion relationships. In: Exercise, edited by B. Whipp, and K. Wasserman. New York: Dekker, 1991, vol. 52, p. 125. (Lung Biol. Health Dis. Ser.)
28. Wasserman, K. Breathing during exercise. N. Engl. J. Med. 298: 780-785, 1978[Medline].
29. Younes, M. Determinants of thoracic excursion. In: Exercise, edited by B. Whipp, and K. Wasserman. New York: Dekker, 1991, vol. 52, p. 4-10. (Lung Biol. Health Dis. Ser.)
30. Younes, M., and G. Kivinen. Respiratory mechanics and breathing pattern during and following maximal exercise. J. Appl. Physiol. 57: 1773-1778, 1984[Abstract/Free Full Text].

0161-7567/97 $5.00 Copyright © 1997 the American Physiological Society



This article has been cited by other articles:


Home page
CirculationHome page
C. C.W. Hsia
Coordinated Adaptation of Oxygen Transport in Cardiopulmonary Disease
Circulation, August 21, 2001; 104(8): 963 - 969.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fee, L. L.
Right arrow Articles by English, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fee, L. L.
Right arrow Articles by English, M. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online